NRX Pharmaceuticals, Inc. Reports Q2 2026 Financial Results

2026-08-14SEC Filing 10-Q (0001437749-26-028027)

Please check the link below for details.

Ticker mentioned:NRXP
Source:Original SEC Document ↗